AbbVie nears $11B deal for Apogee Therapeutics
The Claman Countdown · FBN · Jun 19, 2026 · 34sSign Up Now
Already a subscriber?
Fox Business reports on AbbVie's potential acquisition of Apogee Therapeutics for $10.9 billion in cash. The deal, which values Apogee at a 60% premium, is expected to be announced as early as Monday, marking a significant development in the biotech sector.